RxDoctor Payments DataLook up a doctor →

Rituxan Hycela: payments to doctors

Payments that named Rituxan Hycela as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$55K
Providers
1,165
Transactions
2,241
Average per transaction
$25

The per-transaction average — $25 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,165 providers the average total is $47, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Genentech USA, Inc.$55,07999.9%
Genentech, Inc.$500.1%
← All drugs & devices